Aktiesnakken — Juli 2011
-
folk ihjel....
-
hvis vi kommer derhen at Roche vil købe - så ser vi vist også en helt anden kurs på GEN
aktien -
det tror jeg ikke de får lov til.
-
men de var ikke bange for at bide til bolle med Genentech. Hvor meget var det, de bød for det selskab?
-
insanely meget. kan ikke huske det præcis men det var double digit billions dollars
-
46,8 billions
-
-
genmabs market cap under 0,4 billion
-
Der er rum for forbedring
-
men var det ikke kun for 44% af aktierne?
-
jo i har sku ret
-
så det var en 100 billion dollar valuation. Også lidt anstrengt vil jeg mene
-
men GEN skal vise, at Arzerra bliver mere end nich-drug før selskabet bliver penge værd
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind